chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After 1st dose -What started is that it was multiple things. Even though I'm disabled I've made my own devices to help me do things around the house, I even have a basket sling to help me get up the ladder. The very next day I slept the entire day. The next few days I've been remolding the closet and enjoy woodworking which is a hobby but I was having trouble getting to do it. The next few days was sleeping all day. Then a couple of days I wouldn't, but then it would be back to sleeping for 2-3 days straight. Alarms wouldn't help. Some days I would have trouble even waking up to take my medications on time like I normally would at the same time every day with my alarm. I would only wake up every 3-4 to go to the bathroom and then go back to sleep. After the 2nd dose - it got to me sleeping every 12 hours every day and wouldn't get up till after 1pm every day. I'm constantly having to drink fluids to speak and therefore going to the bathroom, but I was at least able to come down the stairs every day. I would go to the bathroom and fall asleep sitting on the toilet, which is unusual for me. It's not like I was sitting on it for long. I would also fall asleep on the chair and couldn't remember if I went to the restroom or not- it would seem like I had memory loss around the time I would fall asleep. Sometimes coming out of the bathroom heading down the hall and would fall asleep in my wheelchair in the hall and wouldn't wake up on my own or if someone else woke me up. And waking up would be the only way I would know I fell asleep- as if someone turned off my switch. It would happen different ways, while on the phone all of a sudden falling asleep and being woken up when it hits the floor. After 3rd dose- this continued to progress. After 1st dose was sporadic. After 2nd dose it became more frequent, after the 3rd dose - it's now that I'm practically staying in bed all the time. it's difficult to even maintain alertness and staying awake speaking on the phone right now. I find if I give myself a sugar rush it helps to stay awake for a little bit.
Left arm red three inches and a half measured.  Painful to touch & red.  Small blister at center of redness.
stomach/intestinal issues; headache; very miserable; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (stomach/intestinal issues), HEADACHE (headache) and VACCINATION COMPLICATION (very miserable) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 16-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ABDOMINAL DISCOMFORT (stomach/intestinal issues), HEADACHE (headache) and VACCINATION COMPLICATION (very miserable). At the time of the report, ABDOMINAL DISCOMFORT (stomach/intestinal issues), HEADACHE (headache) and VACCINATION COMPLICATION (very miserable) outcome was unknown.            In this case no information about concomitant medications and treatment medications.
Mother reports right arm became red, painful, nodule noted 3 days after vaccine given. Seen by local MD and health dept. No TX given per mom.
broke out w/chickenpox today;mild case, did not spread;not sure if sister had varivax but sister also got chickenpox;
Right shoulder, 13 cm2 induration surrounding injection site with warmth. 2.5 cm diameter erythematous ring around injection site.  No acute distress noted.
Cellulitis around DTaP injection site at 48 out. + fever but none in MD office.
This legal claim was reported by a consumer via a pharmacist and described the occurrence of adverse reaction in a female subject of unspecified age who was vaccinated with BOOSTRIX (GlaxoSmithKline). A physician or other health care professional has not verified this report. On an unspecified date the subject received unspecified dose of BOOSTRIX (unknown route). On 21 July 2014, at an unspecified time after vaccination with BOOSTRIX, the subject experienced adverse reaction. At the time of reporting the outcome of the event was unspecified.
On 12/13/21, Patient was seen for administration of her 2nd dose of Moderna covid vaccine, it was noted that the 1st dose administered on 11/29 at another clinic was only 2 weeks prior and not enough time in-between dose #1 and dose #2. Patient was informed of issue and patient advised that her second dose appointment was originally scheduled for 12/27/21, however she needed to be vaccinated sooner for work, so she called to change her appt to a sooner date and was accommodated. The administering Nurse informed the patient that based on CDC guidelines the vaccination would be considered invalid due to timing and she would need to be revaccinated. Management was notified and to following up with patient.
Patient received his first dose vaccine at 1340. Patient experienced a vasovagal reaction, in which, he feel from his chair and hit his head (unwitnessed). VS within normal limits. Patient refused EMS services. Pt assessed and is A + O x 4 ; walks with steady gait. Educated when to call 911 and to follow-up with healthcare provider.
This spontaneous report was received from a company representative refers to 13 year old patient who is one of his child. On an unknown date, the patient was vaccinated with 1 dose of GARDASIL (lot number, dose and route were not reported) prior to receiving GARDASIL 9 0.5 ml dose, intramuscularly on Monday evening 11-MAY-2015 as the second dose of his HPV vaccination series (lot number not reported). On 13-MAY-2015 (reported as Wednesday), the patient experienced injection site erythema, and injection site warmth and injection site swollen. The patient was not treated for the events. Patient did not sought medical attention. The outcome of events was not reported (also reported that the patient was fine at the time of report). The reporter did not provide the causality between the event and the suspect therapy. No product quality complaint (PQC) was filed. No additional information was provided. This is one of the two reports from the same source. Additional information has been requested.
Patient immediately complained of Nausea and then seemed to pass out and need to be guided to the floor
Started off as general itchiness around site of injection 10 days after the injection. Later the first night, a large hive appeared over the injection site, with redness and swelling around the area. Hives/redness have remained since.
Patient was given Pfizer monovalent vaccine booster instead of Pfizer bivalent booster.  Patient was contacted and was ok with receiving the bivalent vaccine in 2 months.
Two days after receiving flu vaccine, had outbreak of shingles.  Seen by family physician and treated with Depomedrol injection, Oral Prednisone, and Valtrex.  Three days after receiving the vaccine, developed a lump in her throat.  No treatment yet.
she lost total hearing in one ear inside of five minutes/went totally deaf in her right ear; This is a spontaneous report from a contactable consumer reported for herself. A 74-years-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3247 and expiry date: May2021), via an unspecified route of administration on left arm on 28Jan2021 16:00 at SINGLE DOSE for covid-19 immunisation. Medical history included chronic lymphocytic leukaemia, anaemia. The patient's concomitant medications were not reported. The patient previously took morphine and experienced drug hypersensitivity. The patient received the first dose of the Pfizer COVID 19 vaccine on 28Jan2021. On the 30Jan2021 04:00 PM, she lost total hearing in one ear inside of five minutes/she went totally deaf in her right ear. She has had tests done including a CT and MRI but she is still waiting for the results, which reported as under treatment. Adds she doesn't have an appointment yet, but she is supposed to get the next dose 18Feb2021. The event reported as serious with disability, result emergency room/department or urgent care. Outcome of the event was not recovered. Patient is not pregnant at the time of vaccination. No Covid prior vaccination. No covid tested post vaccination.
Significant pain down (L) arm without erythema or edema and residual pain in shoulder jt itself & decreased ROM of (L) shoulder.
Rash on multiple parts of body, Chest, neck, arms, legs. Patient counseled to contact PCP
pt recv vax 15OCT96 & approx 3-4 days p/vax began to develop achiness in muscles & all over body;16 days p/vax still has achiness & stiffness & some pain in buttocks when sits;pt will see PMD 1NOV96;
Patient presented to Outdoor Tent Clinic requesting booster dose Pfizer vaccine. Pt stated he did not bring his card. When questioned about the date of his last dose and if it were 5-6 months ago, pt stated he did not recall the date but agreed that it was 5 months ago. Pt vaccinated with booster dose Pfizer Adult  covid vaccine. During documentation of vaccine administration in EHR, it was discovered patient received booster dose too early, 28 days after 2nd dose.  Pt did not have side effects from this dose.
Vaccine was stored in the fridge on 24-Jan-2023/Vaccine administered on 27-Feb-2023; no adverse event; Moderna Bivalent vaccine was administered after 30-day Use By Date.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna Bivalent vaccine was administered after 30-day Use By Date.), PRODUCT STORAGE ERROR (Vaccine was stored in the fridge on 24-Jan-2023/Vaccine administered on 27-Feb-2023) and NO ADVERSE EVENT (no adverse event) in a 63-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 065H22A) for COVID-19 prophylaxis.     No Medical History information was reported.  On 27-Feb-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 27-Feb-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna Bivalent vaccine was administered after 30-day Use By Date.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored in the fridge on 24-Jan-2023/Vaccine administered on 27-Feb-2023) and NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna Bivalent vaccine was administered after 30-day Use By Date.), PRODUCT STORAGE ERROR (Vaccine was stored in the fridge on 24-Jan-2023/Vaccine administered on 27-Feb-2023) and NO ADVERSE EVENT (no adverse event) outcome was unknown.     For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Moderna Bivalent vaccine was administered after 30-day Use By Date.) and PRODUCT STORAGE ERROR (Vaccine was stored in the fridge on 24-Jan-2023/Vaccine administered on 27-Feb-2023).    No concomitant medications were reported.  Vaccine was stored in the fridge on 24-Jan-2023.   Patient did not report any side effects.  No treatment medications were reported.
Pain on a scale of 1-10 rated 9.5; This is a spontaneous case initially received from consumer on 26-Aug-2019, concerning a female, 71-years-old patient.    The patient's medical history included opent heart surgery and heart valve replacement, multiple allergies including latex allergy, joint pain, muscle pain and walking with cane.   The patient's vaccine history included Afluria Trivalent for unknown indication. The patient's concomitant medication included Tylenol (paracetamol) for unknown indication. The patient reported taking ten drugs, but did not wish to list them all.  On an unspecified date in 2017, the patient was administered Afluria Quad [influenza vaccine, batch number, route of administration, anatomical location, expiry date: not provided] for influenza prophylaxis.   On an unspecified date, after vaccination, the patient experienced horrific side effects of pain on a scale of 1-10 she rated 9.5.   The outcome of the event pain was resolved.    The reported did not provide causality assessment.  This case is linked to 201904509, concerning the same patient.  Non-significant follow-up received from other non-health professional on 09-Oct-2019: Additional agency reference number 'SEQ19-02302' added. No changes in narrative.   Company Comment: The patient developed pain on unknown date after vaccination with the suspect product Afluria Quad (influenza vaccine). Chronology is plausible. Medical history of joint pain, muscle pain and advanced age (71) may have contributed to development of the event. Based on provided information, causal role of the suspect product cannot be totally excluded and is assessed as related.; Reporter's Comments: The patient developed pain on unknown date after vaccination with the suspect product Afluria Quad (influenza vaccine). Chronology is plausible. Medical history of joint pain, muscle pain and advanced age (71) may have contributed to development of the event. Based on provided information, causal role of the suspect product cannot be totally excluded and is assessed as related.
I got a very strange rash all over my back - went to urgent care - they gave me a steroid pill - still hasnt gone completely away - Ive also have had pains in my nerves in my left leg and up to my chest [ heart] tightness in my chest and tingling in my arms and legs. Still having those.  But about a week or so later went to urgent care for that and felt like i was going to faint.
4:20 Received Vaccine  4:30: Began with feeling  flush, c/o "hot flash", face visibly red. Advised to remove hat and goggles, given water and a cold cloth. Reported no change.  4:35 Walked to open window, sat in chair. C/O dizziness while sitting, no c/o feeling faint. 77, 138/88, 97%. Remained seated.  4:50 Dizziness resolved, ambulated back to own seat and placed goggles and hat back on, appeared ashen. 77, 97%. C/O feeling of "moving through mud" Given 4 oz Orange Juice and advised to sit and wait.  4:55 All symptoms resolved within minutes. Remained under observation and remained stable.  5:00 Released from observation
Patient with allergic rhinitis who can never smell anything can smell for 2 days after getting the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (Patient with allergic rhinitis who can never smell anything can smell for 2 days after getting the vaccine) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041C21A and 043B21A) for COVID-19 vaccination.     Concurrent medical conditions included Allergic rhinitis (Can never smell anything).   On 24-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-May-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (Patient with allergic rhinitis who can never smell anything can smell for 2 days after getting the vaccine). On 25-May-2021, THERAPEUTIC RESPONSE UNEXPECTED (Patient with allergic rhinitis who can never smell anything can smell for 2 days after getting the vaccine) had resolved.            No concomitant medication information was provided. No treatment information was provided.   This case was linked to MOD-2022-455403, MOD-2022-455409 (Patient Link).
Faint after receiving shots - very nervous dizzy & nauseous. Gave her candy, water, cold compress - check vital signs after stabilizing client B/P 100/60 - Pulse 72 - Client mother verbalize no breakfast.
On 5-5-2022, I started having a stuffy nose, cough, headache and body aches. I took a home Covid test on this day and it was negative. My symptoms increased in severity. I took a second home Covid test on 5-8 and it was negative as well. I took another home test on 5-11 and it was positive. I called my doctors office and had a telehealth visit on that same day. They prescribed Cetirizine, Flonase and a pain medication due to headaches. On 5-12, I took a drive thru Covid test and it was positive as well. I am doing very well today and all symptoms have resolved. I am reporting a breakthru case of Covid.
8/12/10 Temp 102, vomiting, rash on lower face, cheeks swollen.
gave 0.25 mL to an older adults; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of ACCIDENTAL UNDERDOSE (gave 0.25 mL to an older adults) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7146B) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On an unknown date, the patient experienced ACCIDENTAL UNDERDOSE (gave 0.25 mL to an older adults) and NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (gave 0.25 mL to an older adults) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (gave 0.25 mL to an older adults).    No concomitant medication was reported.  It was reported that they gave 0.5 but initially charted 0.25 and changed it afterwards to 0.5. There was over a milliliter left of vaccine still in the vial after supposedly 5 full doses might have been withdrawn.  The vial fill volume was possibly too high. The vial was punctured 5 times. 5 doses were extracted from the vial.  The technique was unknown to used to load the syringe. No treatment medication was reported.  This case was for Adult patient 3.   This case was linked to US-MODERNATX, INC.-MOD-2022-673577, US-MODERNATX, INC.-MOD-2022-673580, US-MODERNATX, INC.-MOD-2022-673533 (Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 16-Nov-2022: Additional follow-up received QE id was added.; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-673577:Case for Adult patient 2 US-MODERNATX, INC.-MOD-2022-673580:Case for Adult patient 4 US-MODERNATX, INC.-MOD-2022-673533:Case for Adult patient 1
my arm is swelling, and moving down towards my elbow; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (my arm is swelling, and moving down towards my elbow) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (my arm is swelling, and moving down towards my elbow). At the time of the report, PERIPHERAL SWELLING (my arm is swelling, and moving down towards my elbow) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. No treatment medication was reported.  Patient reported that they had the Moderna shot on Thursday at noon.
Genital herpes/ herpes outbreaks/ had 3 separate outbreaks; This case was reported by a physician via sales rep and described the occurrence of genital herpes in a elderly female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, 14 days after receiving Shingrix, the patient experienced genital herpes. On an unknown date, the outcome of the genital herpes was unknown.   The reporter considered the genital herpes to be unrelated to Shingrix.  Additional case details were provided as follows: Age at vaccination was not reported. The reporter stated that, the patient was seen in office last week on 16th September 2019.  The reporter was unsure of date of receiving Shingrix. Upon reviewing immunizations profile of patient, the reporter stated the 2nd dose of Shingrix needs to be given to the patient but they also mentioned that, the patient had an outbreak of genital herpes 2 weeks after receiving 1st dose of Shingrix. Exact onset date was not known. The patient also had three separate outbreaks after 2 weeks intervals subsequent to initial outbreak. The reporter did not think that, the event genital herpes outbreak was related to receiving Shingrix. The reporter agreed for follow up.
Patient had swelling /redness/ pain at injection site. Dr diagnosed her with cellulitis, she was prescribed KEFLEX for tx.
Patient received vaccine at 10:30 am.  Patient waiting in monitoring area and fell out of the chair to the floor hitting the R side of his head on the floor at 10:35am.  O2 sats 78%, P-78 bpm  Unable to obtain a bp.  Patient alert and talking.  Patient seized for 30 seconds after sitting up.  O2 @ 2L per NC administered.  911 called at 10:43 am.  Patient taken by ambulance to ER at 10:53am.
Pt recv vax on 11/12/98; on 11/14/98 pt exp dizziness, vomiting, blurred vision, chills & fever, shakes
A report has been received from a Health Professional concerning a patient born on 22-Apr-2010, Male subject, who had been receiving Nasal FLUMIST, 0.1mL, in each nostril intranasally. FLUMIST started on an unknown date. The outcome of the event of given expired medication is unknown. The report was considered to be non-serious.